Clinical TrialsSearch results
Number of results: 70335
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Not yet recruiting
- Work of breathing measured by PAV+ during spontaneous breath trial and extubation outcome
- Adult patients are mechanically ventilated for acute respiratory failure
- Tokyo Bay Urayasu Ichikawa Medical Center
- 2018-05-01
Other
- Work for a university hospital nurse occupation continued and sympatly scale score relation
- no
- Kansai Medical University Hospital Nursing unit
- 2018-10-20
Not yet recruiting
- WONDER-02: plastic stent vs. lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic pseudocysts: a multicentre randomised non-inferiority trial
- Symptomatic pancreatic pseudocyst
- Nakai Yousuke
- 2023-11-10
Not yet recruiting
- WONDER-02: plastic stent vs. lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic pseudocysts-a multicentre randomised non-inferiority trial
- Pancreatic Pseudocyst
- The University of Tokyo
- 2023-10-30
Other
- WMU-NPC-1
- Patients with cutaneous manifestation with vascular
- Jinnin Masatoshi
- 2021-11-26
Other
- WJOG7512L:A randomized phase III study of maintenance therapy with TS-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus TS-1 for advanced or relapsed squamous cell carcinoma of the lung
- Advanced or relapsed squamous cell carcinoma of the lung
- West Japan Oncology Group
- 2013-04-02
Other
- WJOG6510GTR: Study of genetic biomarkers to predict efficacy in patients with wild-type KRAS metastatic colorectal cancer receiving Panitumumab + Irinotecan or Cetuximab + Irinotecan
- Advanced colorectal cancer
- West Japan Oncology Group
- 2012-08-28
Other
- WJOG6510G : Randomized phase II study of panitumumab + irinotecan versus cetuximab + irinotecan in Patients Wild-Type KRAS Metastatic Colorectal Cancer Following Treatment with Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy
- advanced colorectal cancer
- West Japan Oncology Group
- 2011-11-01
Recruiting
- WJOG17223L, TURNING trial
- TTF-1 negative NSCLC
- Tachihara Motoko
- 2025-01-15
Other
- WJOG11118L
- Lung Cancer
- Hirotsugu Kenmotsu
- 2020-09-29